Lung Cancer (LNCR)

Alias:

Lung Carcinoma

Non-Small Cell Lung Carcinoma

Nsclc

Adenocarcinoma of Lung, Response to Tyrosine Kinase Inhibitor in

Lung Cancer, Protection Against

Adenocarcinoma of Lung, Somatic

Lung Cancer, Susceptibility to

Lung Non-Small Cell Carcinoma

Non-Small Cell Lung Cancer

Malignant Neoplasm of Lung

Nonsmall Cell Lung Cancer

Alveolar Cell Carcinoma

Carcinoma of Lung

Lung Neoplasms

Lung Neoplasm

Nonsmall Cell Lung Cancer, Response to Tyrosine Kinase Inhibitor in

Nonsmall Cell Lung Cancer, Susceptibility to

Nonsmall Cell Lung Cancer, Somatic

Primary Malignant Neoplasm of Lung

Bronchioloalveolar Adenocarcinoma

Carcinoma, Non-Small-Cell Lung

Carcinoma Non-Small Cell Lung

Cancer, Lung, Non-Small Cell

Lung Cancer, Resistance to

Malignant Tumor of Lung

Adenocarcinoma of Lung

Lung Malignant Tumors

Respiratory Carcinoma

Lung Cancer, Somatic

Malignant Lung Tumor

Pulmonary Carcinoma

Pulmonary Neoplasms

Cancer of Bronchus

Cancer of the Lung

Lung Malignancies

Pulmonary Cancer

Neoplasm of Lung

Lung Carcinomas

Cancer of Lung

Lung Cancers

Cancer, Lung

Cancer Lung

Lncr

Favorite

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Lung Cancer, also known as lung carcinoma, is related to lung cancer susceptibility 3 and small cell cancer of the lung, and has symptoms including cough, chest discomfort and weight loss. An important gene associated with Lung Cancer is BRAF (B-Raf Proto-Oncogene, Serine/Threonine Kinase), and among its related pathways/superpathways are Innate Immune System and Infectious disease. The drugs Diclofenac and Amiodarone have been mentioned in the context of this disorder. Affiliated tissues include lung and brain, and related phenotypes are lung adenocarcinoma and non-small cell lung carcinoma

Related ID：

MALACARDS：LNG032

OMIM：211980

MESH：D002289